EUVIMEDEUVIMED entdecken
Crossref

Peritendinous leucocyte‐poor platelet‐rich plasma injections improve symptomatic chronic rotator cuff tendinopathies and partial‐thickness rotator cuff tears: A retrospective study with medium‐term follow‐up

Emmanouil Brilakis iD, Kyriakos Ioannidis, Leonidas Roumeliotis iD, Maria Papatzikou, Jean Michel Hovsepian iD, Theodorakys Marín Fermín iD

Knee Surgery, Sports Traumatology, Arthroscopy · 2026-04 · 34 (4) · 1414-1420

DOI: 10.1002/ksa.70272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 11.01.2026. Verfasst von Emmanouil Brilakis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brilakis Orthopaedics, Athens Medical Group, Athens, Greece. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Rotator Cuff Injuries, Tendinopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the effect of a peritendinous leucocyte‐poor platelet‐rich plasma (PRP) injection protocol on patient‐reported outcome measures (PROMs) in treating chronic rotator cuff tendinopathy (CRCT) or partial‐thickness rotator cuff tears (PTT).

Methods

A single‐centre retrospective case series of prospectively collected data was conducted. All patients diagnosed with CRCT or PTT undergoing peritendinous leucocyte‐poor PRP injection were considered for eligibility. Inclusion criteria were: (1) active patients; (2) with proven CRCT or PTT of any rotator cuff tendon regardless of the aetiology and location on magnetic resonance imaging; (3) who had failed a conservative management programme; (4) with a complete data set from their scheduled follow‐ups. Patient demographic data and written assessment visual analogue scale (VAS) for pain at rest, at night and on movement, single assessment numeric evaluation (SANE) and American Shoulder and Elbow Surgeons (ASES) scores, were collected at baseline and 6, 12 and 24 weeks, and annually post‐injection.

Results

A total of 47 patients, 22 males and 35 females, with a mean age of 49.6 ± 16.1 (range: 20–76), and a mean follow‐up of 47 ± 17.4 months (range: 4–68.5) were included. No patient was lost at follow‐up. Peritendinous leucocyte‐poor PRP injection significantly improved VAS for pain (at rest, at night and on movement), SANE and ASES scores at the last follow‐up ( p < 0.001). Post‐injection VAS for pain median was 0 at rest, at night and during movement. The SANE (mean 43.4 ± 16.3 to 92.2 ± 13.4) and ASES score (mean 39.7 ± 12 to 95.6 ± 9.09) improvement surpassed the minimum clinically important difference.

Conclusion

Ultrasound‐guided peritendinous leucocyte‐poor PRP injections may yield sustained medium‐term improvements in PROMs in CRCT or PTT. These findings support the use of ultrasound‐guided peritendinous leucocyte‐poor PRP injections as an effective and durable non‐surgical treatment option for managing CRCT and PTT. Level of Evidence Level IV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaRotator Cuff InjuriesTendinopathyHumansRetrospective StudiesFemaleMaleMiddle AgedFollow-Up StudiesAdultPain MeasurementAgedChronic DiseasePatient Reported Outcome MeasuresTreatment OutcomeRotator CuffInjections, Intra-ArticularLeukocytes

Stichwörter der Autor:innen

orthobiologicsplatelet‐rich plasmaregenerative medicinerotator cuffshouldertendinopathy

Autor:innen und Institutionen

  • Brilakis Orthopaedics, Athens Medical Group, Athens, Greece.
  • 3rd Orthopaedic Department, Hygeia Hospital, Athens, Greece.
  • Department of Orthopedic Sports Medicine and Arthroscopic Surgery, University of Augsburg, Hessing Stiftung, Augsburg, Germany.
  • Clínica Santa Sofía, Caracas, Venezuela.

ORCID-Profile: Emmanouil Brilakis, Leonidas Roumeliotis, Jean Michel Hovsepian, Theodorakys Marín Fermín

Zitieren

APA

Brilakis, E., Ioannidis, K., Roumeliotis, L., Papatzikou, M., Hovsepian, J. M., & Marín Fermín, T. (2026). Peritendinous leucocyte‐poor platelet‐rich plasma injections improve symptomatic chronic rotator cuff tendinopathies and partial‐thickness rotator cuff tears: A retrospective study with medium‐term follow‐up. Knee Surgery, Sports Traumatology, Arthroscopy, 34(4), 1414-1420. https://doi.org/10.1002/ksa.70272

Vancouver

Brilakis E, Ioannidis K, Roumeliotis L, Papatzikou M, Hovsepian JM, Marín Fermín T. Peritendinous leucocyte‐poor platelet‐rich plasma injections improve symptomatic chronic rotator cuff tendinopathies and partial‐thickness rotator cuff tears: A retrospective study with medium‐term follow‐up. Knee Surgery, Sports Traumatology, Arthroscopy. 2026;34(4):1414-1420. doi:10.1002/ksa.70272

BibTeX
@article{Brilakis2026,
  author = {Brilakis, Emmanouil and Ioannidis, Kyriakos and Roumeliotis, Leonidas and Papatzikou, Maria and Hovsepian, Jean Michel and Marín Fermín, Theodorakys},
  title = {Peritendinous leucocyte‐poor platelet‐rich plasma injections improve symptomatic chronic rotator cuff tendinopathies and partial‐thickness rotator cuff tears: A retrospective study with medium‐term follow‐up},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2026},
  volume = {34},
  number = {4},
  pages = {1414--1420},
  doi = {10.1002/ksa.70272}
}
Kostenlos starten →